Bright Minds Biosciences (DRUG) vs Evolus (EOLS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Evolus (EOLS) has outperformed Bright Minds Biosciences (DRUG) over the past year, gaining 23.6% versus a gain of 2.3%. Over five years, DRUG leads with a +40.0% price change compared with +0.9% for EOLS. Bright Minds Biosciences is the larger company by market cap ($512.9 million vs $511.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DRUG | EOLS |
|---|---|---|
| Share price | $52.00 | $7.74 |
| Market cap | $512.93M | $511.23M |
| 1-day change | +7.77% | +4.88% |
| YTD return | -33.37% | +16.39% |
| 1-year return | +2.30% | +23.64% |
| 5-year return | +39.97% | +0.91% |
| Forward P/E | — | 26.46 |
| EPS (TTM) | $-2.05 | $-0.53 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $123.75 | $9.31 |
| 52-week low | $47.35 | $3.86 |
| Distance from 52-week high | -57.98% | -16.86% |
| Average volume | 154.58K | 907.37K |
| Shares outstanding | 9.86M | 66.05M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- EOLS has outperformed DRUG by 21.3 percentage points over the past year.
DRUG vs EOLS FAQ
Which is bigger, Bright Minds Biosciences or Evolus?
Bright Minds Biosciences (DRUG) is larger, with a market capitalization of $512.93M compared with $511.23M for Evolus (EOLS).
Which stock has performed better over the past year, DRUG or EOLS?
EOLS returned +23.64% over the past 12 months, compared with +2.30% for DRUG (price return, excluding dividends). Past performance does not predict future results.
Are Bright Minds Biosciences and Evolus in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.